Emerging innovations in cold plasma therapy against cancer: A paradigm shift-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging innovations in cold plasma therapy against cancer: A paradigm shift

Published:2022-09 Issue:9 Volume:27 Page:2425-2439
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Kumar Dubey Sunil,Dabholkar Neha,Narayan Pal Udit,Singhvi Gautam,Kumar Sharma Navin,Puri Anu,Kesharwani Prashant

Funder

Science and Engineering Research Board

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference161 articles.

1. Review of cancer from perspective of molecular;Hassanpour;J Cancer Res Pract,2017

2. National Cancer Institute. Cancer Statistics 2021.

3. Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer;Pashirzad;Process Biochem,2022

4. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer;Sheikh;Biomed Pharmacother,2022

5. Surface engineered nanocarriers for the management of breast cancer;Nitheesh;Mater Sci Eng C,2021

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effects of plasma-activated medium in combination with Baicalin against neuronal damage;Heliyon;2024-08

2. Targeting colon cancer and normal cells with cold plasma-activated water: Exploring cytotoxic effects and cellular responses;Physics of Plasmas;2024-08-01

3. Unveiling the Potential: Can Machine Learning Cluster Colorimetric Images of Cold Atmospheric Plasma Treatment?;Advanced Intelligent Systems;2024-06-27

4. Reactive Species Risk Assessment Using Optimized HET-CAM Safety Evaluation of Feed Gas-Modified Gas Plasma Technology and Anticancer Drugs;ACS Applied Materials & Interfaces;2024-06-26

5. Comprehensive studies on the biological activities of human metastatic (MDA-MB-231) and non-metastatic (MCF-7) breast cancer cell lines, directly or combinedly treated using non-thermal plasma-based approaches;Toxicology in Vitro;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3